Tava’s network of therapists will be added to Health Advocate’s existing network.
The world is going remote.
While the service existed beforehand, the pandemic pushed telehealth into the spotlight. For many patients, it wasn’t just safer to be able to visit a doctor from the comfort of their own home, it was much simpler. This is especially true for patients visiting their regular doctors for recurring conditions. Due to the pre-existing relationship, doctors can often provide the necessary prescriptions based off of a description of symptoms alone.
As the pandemic receded, the value of teletherapy remained. Since then, more and more companies are working to expand access to teletherapy services.
Health Advocate announced that it has partnered with Tava Health to expand its access to telehealth.1 This partnership will allow members of Health Advocate to access Tava Health’s nationwide network of therapists. These new therapists will be added to Health Advocate’s existing network of therapists in order to provide members with faster and more reliable access to treatment.
In a press release, Health Advocate president and CEO Jeff Cordell said, “Emotional and mental health is one of Health Advocate's primary areas of focus, and we are committed to offering innovative solutions and services to help our clients ensure their employees' access to high-quality behavioral health resources. We are thrilled to partner with Tava to expand the options our members have to securely, quickly and easily connect to the care they need. The results we're seeing so far speak to the positive reception from our members, and we look forward to continuing to grow this relationship."
In the same press release, Tava Health CEO and co-founder Dallen Allred said, “Our partnership with Health Advocate amplifies our shared commitment to improving access to mental health care. By integrating Tava's extensive network of licensed therapists with Health Advocate's virtual support program, we're empowering Health Advocate members to meet with a therapist within a day. This collaboration underscores our dedication to breaking down barriers to care and ensuring that everyone can access the support they need for their emotional well-being."
Health Advocate recently announced an addition to its team of medical directors.2
In February of this year, the company announced that Dr. Keri Robertson had joined the team in a key management role related to clinical care management and population health management. She was brought on board due to her expertise in data analytics and understanding the social determinants of health. Robertson is joining Health Advocate from her previous role as a physician quality advisor at Endeavor Health System in Illinois.
In a press release issued at the time, Cordell said, “As Health Advocate continues to improve our industry-leading solutions, Dr. Robertson is perfectly positioned to enhance the quality of support and care for our members who face serious medical issues. Her unique background in quality improvement, enhancing patient experiences and outcomes in marginalized communities, and emergency medicine are instrumental as we launch our best-of-breed Clinical Care Management program, among other new offerings."
In the same press release, Dr. Robertson said, “As an emergency physician, I have unique insight into the challenges of navigating the complexities of the U.S. healthcare system. I am excited to be part of the Health Advocate team where we educate, engage and advocate for our members and assist them on their healthcare journeys."
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.